Macular Degeneration, Diabetic Retinopathy Reversed

Dr. Zhang.jpg

Dr. Kang Zhang, MD, PhD, Associate Professor and an RPB Lew R. Wasserman Merit Awardee at the University of Utah, John A. Moran Eye Center uses a state-of-the-art genetic analyzer to accelerate the discovery of genes involved in blinding eye diseases.

Two leading causes of blindness can be reversed or even prevented by drugs that activate a protein found in blood vessel cells. The discovery is an example of basic science research yielding a discovery with direct clinical applications.

top

March 20, 2008

Diabetic Retinopathy

Related News: Diabetic Retinopathy

New study shows that diabetic eye disease is up, but the most severe forms are down

Data from an RPB and MTMVI-supported study showed that while diabetes-related eye diseases doubled since 2014, the most severe forms of the disease have decreased.

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2025 Recipient of RPB David F. Weeks Award for Outstanding Vision Research

Maria Bartolomeo Grant, MD, is recognized for ground-breaking contributions to the field of vision research.

New Grants for Big Data Research to Improve Vision Care

Researchers Build An “Aging Clock” To Help Treat Eye Disease

The new way to measure ocular aging opens treatment avenues for numerous eye diseases.

RPB-Supported Researcher Makes Progress on Diabetic Retinopathy Treatment

Dr. Akrit Sodhi at Johns Hopkins Medicine has published a new study showing promise for an experimental treatment to prevent or slow vision loss in people with diabetes.